Treatment of skeletal Erdheim-Chester disease with zoledronic acid: Case report and proposed mechanisms of action

Rheumatology International

Volumn 27, Issue 3, 2007, Pages 303-307

  Srikulmontree, Thitinan ^a,b   Massey, H Davis ^c   Roberts, W Neal ^b  

^a Hunter Holmes McGuire Medical Center   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Bisphosphonate; Bone biology; Erdheim Chester disease diagnosis; Erdheim Chester disease pathology; Erdheim Chester disease treatment

Indexed keywords

ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CELECOXIB; COCODAMOL; COLCHICINE; CORTICOSTEROID; CYTOKINE; TRIAMCINOLONE; ZOLEDRONIC ACID;

ADULT; ARTICLE; BACTERIAL ARTHRITIS; BONE BIOPSY; CASE REPORT; CELL CULTURE; ERDHEIM CHESTER DISEASE; FEMALE; HUMAN; LABORATORY TEST; LAMINECTOMY; LIGAMENT; MACROPHAGE; MACROPHAGE MIGRATION; PRIORITY JOURNAL; SINGLE DRUG DOSE; SURGICAL DRAINAGE; X RAY FILM;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; ERDHEIM-CHESTER DISEASE; FEMALE; HUMANS; IMIDAZOLES; MIDDLE AGED;

EID: 33846179334     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0190-8     Document Type: Article

References (15)

1. Veyssier-Belot C, Cacoub P, Caparros-Lefebbre D, Wechsler J, Brun B, Martine R, Wallaert B, Petit H, Grimaldi A, Wechsler B, Godeau P (1996) Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine 75(3):157-169
2. Jendro MC, Zeidler H, Rosenthal H, Haller H, Schwarz A (2004) Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol 23(1):52-56
3. Myra C, Sloper L, Tighe PJ, McIntosh RS, Stevens SE, Gregson RH, Sokal M, Haynes AP, Powell RJ (2004) Treatment of Erdheim-Chester disease with cladribine: a rational approach. Br J Ophthalmol 88(6):844-847
4. Esmaeli B, Ahmadi A, Tang R, Schiffman J, Kurzrock R (2001) Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease. Am J Ophthalmol 132(6):945-947
5. Kamizono J, Okada Y, Shirahata A, Tanaka Y (2002) Bisphosphonate induces remission of refractory osteolysis in Langerhans cell histiocytosis. J Bone Miner Res 17(11):1926-1928
6. Brown RE (2001) Bisphosphonates as antialveolar macrophage therapy in pulmonary Langerhans cell histiocytosis? Med Pediatr Oncol 36(6):641-643
7. Eyigor S, Kirazi Y, Memis A, Basdemir G (2005) Erdheim-Chester disease: the effect of bisphosphonate treatment - a case report. Arch Phys Med Rehabil 86:1053-1057
8. Farran RP, Zaretski E, Egeler RM (2001) Treatment of Langerhans cell histiocytosis with pamidronate. J Pediatr Hematol Oncol 23(1):54-56
9. Braiteh F, Boxrud C, Esmaeli B, Kurzrock R (2005) Successful treatment of Erdheim-Chester disease, a non-Langerhans cell histiocytosis, with interferon-alpha. Blood. Jul 14 [Epub ahead of print]
10. Goto H, Inaba M, Kobayashi K, Imanishi Y, Kumeda Y, Inui K, Okada F, Nishizawa Y (2003) Successful treatment of multicentric reticulohistiocytosis with alendronate. Arthritis Rheum 48(12):3538-3541
11. Mossetti G, Rendina D, Numis FG, Somma P, Postiglione L, Nunziata V (2003) Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonhate treatment in Erdheim-Chester disease. Clin Exp Rheumatol 21(2):232-236
12. Bukowski JF, Dascher CC, Das H (2005) Alternative bisphosphonate targets and mechanisms of action. Biochem Biophys Res Commun 328:746-750
13. Al-Quran S, Reith J, Bradley J, Rimsza L (2002) Erdheim-Chester disease: case report, PCR-based analysis of clonality, and review of literature. Mod Pathol 15(6):666-672
14. Santini D, Vincenzi B, Dicuonzo G, Avvisati G, Massacesi C, Battistoni F, Gavasci M, Rocci L, Tirindelli MC, Altomare V, Tocchini M, Bonsignori M, Tonini G (2003) Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients. Clin Cancer Res 9:2893-2897
15. Li EC, Davis LE (2003) Zoledronic acid: a new parenteral bisphosphonate. Clin Ther 25(11):2669-2699